Inclusion-body myositis associated with Alzheimer's disease

Case Reports in Medicine

Volumn 2013, Issue , 2013, Pages

  Levacic, Danijela ^a   Peddareddygari, Leema Reddy ^b   Nochlin, David ^a   Sharer, Leroy R ^c   Grewal, Raji P ^d  

^a NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

^b Neurogenetics Foundation   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d ST FRANCIS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; CASE REPORT; COGNITIVE DEFECT; DISEASE COURSE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HYDROCEPHALUS; MEMORY DISORDER; MUSCLE BIOPSY; MUSCLE DISEASE; MYOSITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPORADIC INCLUSION BODY MYOSITIS; WEAKNESS;

EID: 84975165920     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2013/536231     Document Type: Article

References (10)

1. Dalakas M. C., Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies. Nature Clinical Practice Neurology 2006 2 8 437 447 2-s2.0-33746530058 10.1038/ncpneuro0261 (Pubitemid 44137945)
2. Roos P. M., Vesterberg O., Nordberg M., Inclusion body myositis in Alzheimer's disease. Acta Neurologica Scandinavica 2011 124 3 215 217 2-s2.0-79961186180 10.1111/j.1600-0404.2010.01461.x
3. Askanas V., Engel W. K., Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: diseases of oxidative stress and aging? Archives of Neurology 1998 55 7 915 920 2-s2.0-0031864547 10.1001/archneur.55.7.915 (Pubitemid 28335109)
4. Askanas V., Engel W. K., Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease. Current Rheumatology Reports 2002 4 5 427 433 2-s2.0-0036778097
5. Askanas V., Engel W. K., Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain: recent approaches to diagnosis and pathogenesis, and relation to aging. Scandinavian Journal of Rheumatology 1998 27 6 389 405 2-s2.0-0031728797 (Pubitemid 28535618)
6. Murphy M. P., Golde T. E., Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether? Neurology 2006 66 2, supplement 1 S65 S68 2-s2.0-33644869496 (Pubitemid 43739987)
7. Askanas V., Engel W. K., Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2001 60 1 1 14 2-s2.0-0035145398 (Pubitemid 32097001)
8. Watts G. D. J., Wymer J., Kovach M. J., Mehta S. G., Mumm S., Darvish D., Pestronk A., Whyte M. P., Kimonis V. E., Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nature Genetics 2004 36 4 377 381 2-s2.0-1842483843 10.1038/ng1332 (Pubitemid 38437260)
9. Felice K. J., North W. A., Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period. Medicine 2001 80 5 320 327 2-s2.0-0034829106 10.1097/00005792-200109000-00006 (Pubitemid 32879294)
10. Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., Taylor J. O., Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989 262 18 2551 2556 2-s2.0-0024317904